Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 633 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared with SoC Antiemetic Prophylaxis MOST POPULAR A Daily Survival Kit for Serious Illness September 8, 2021 Meet Rosalie: St. Jude Children’s Research Hospital’s New Service Dog For... October 19, 2021 2021 ASCO Annual Meeting Research Round Up: Advances in Genitourinary Cancers June 23, 2021 Managing Cancer Pain: Are Better Approaches on the Horizon? January 23, 2019 Load more HOT NEWS Leading Change in Cancer Clinical Research, Because Our Patients Can’t Wait CEDM Reveals A Clearer Image Of Potential Breast Cancer And Reduces... An apple a day keeps the doctor away EMA Recommends Granting a Conditional Marketing Authorisation for Trastuzumab Deruxtecan
